Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018

Publisher Name :
Date: 08-Jun-2018
No. of pages: 100
Inquire Before Buying

This report studies the global Alpha- Antitrypsin Deficiency Treatment market status and forecast, categorizes the global Alpha- Antitrypsin Deficiency Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Alpha- Antitrypsin Deficiency Treatment market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

- Adverum Biotechnologies, Inc.

- Alnylam Pharmaceuticals, Inc.

- Applied Genetic Technologies Corporation

- Arrowhead Pharmaceuticals, Inc.

- Carolus Therapeutics, Inc.

- Cevec Pharmaceuticals GmbH

- Dicerna Pharmaceuticals, Inc.

- Digna Biotech, S.L.

- Editas Medicine, Inc.

- Grifols, S.A.

- Inhibrx

- Intellia Therapeutics, Inc.

- International Stem Cell Corporation

- Ionis Pharmaceuticals, Inc.

- Kamada Ltd.

- Polyphor Ltd.

- ProMetic Life Sciences Inc.

- rEVO Biologics, Inc.

- Sangamo BioSciences, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- CT-2009

- POL-6014

- ARO-AAT

- ALNAAT-02

- Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Clinic

- Hospital

- Others

The study objectives of this report are:

- To analyze and study the global Alpha- Antitrypsin Deficiency Treatment sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Alpha- Antitrypsin Deficiency Treatment manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alpha- Antitrypsin Deficiency Treatment are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Alpha- Antitrypsin Deficiency Treatment Manufacturers

Alpha- Antitrypsin Deficiency Treatment Distributors/Traders/Wholesalers

Alpha- Antitrypsin Deficiency Treatment Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Alpha- Antitrypsin Deficiency Treatment market, by end-use.

Detailed analysis and profiles of additional market players.

Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018

Table of Contents
Global Alpha- Antitrypsin Deficiency Treatment Market Research Report 2018
1 Alpha- Antitrypsin Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Alpha- Antitrypsin Deficiency Treatment
1.2 Alpha- Antitrypsin Deficiency Treatment Segment by Type (Product Category)
1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Alpha- Antitrypsin Deficiency Treatment Production Market Share by Type (Product Category) in 2017
1.2.3 CT-2009
1.2.4 POL-6014
1.2.5 ARO-AAT
1.2.6 ALNAAT-02
1.2.7 Others
1.3 Global Alpha- Antitrypsin Deficiency Treatment Segment by Application
1.3.1 Alpha- Antitrypsin Deficiency Treatment Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Alpha- Antitrypsin Deficiency Treatment Market by Region (2013-2025)
1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Alpha- Antitrypsin Deficiency Treatment (2013-2025)
1.5.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue Status and Outlook (2013-2025)
1.5.2 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production Status and Outlook (2013-2025)
2 Global Alpha- Antitrypsin Deficiency Treatment Market Competition by Manufacturers
2.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Alpha- Antitrypsin Deficiency Treatment Production and Share by Manufacturers (2013-2018)
2.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Share by Manufacturers (2013-2018)
2.3 Global Alpha- Antitrypsin Deficiency Treatment Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Alpha- Antitrypsin Deficiency Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Alpha- Antitrypsin Deficiency Treatment Market Competitive Situation and Trends
2.5.1 Alpha- Antitrypsin Deficiency Treatment Market Concentration Rate
2.5.2 Alpha- Antitrypsin Deficiency Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity and Market Share by Region (2013-2018)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Production and Market Share by Region (2013-2018)
3.3 Global Alpha- Antitrypsin Deficiency Treatment Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Alpha- Antitrypsin Deficiency Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption by Region (2013-2018)
4.2 North America Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.3 Europe Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.4 China Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.5 Japan Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.7 India Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
5 Global Alpha- Antitrypsin Deficiency Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Alpha- Antitrypsin Deficiency Treatment Production and Market Share by Type (2013-2018)
5.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
5.3 Global Alpha- Antitrypsin Deficiency Treatment Price by Type (2013-2018)
5.4 Global Alpha- Antitrypsin Deficiency Treatment Production Growth by Type (2013-2018)
6 Global Alpha- Antitrypsin Deficiency Treatment Market Analysis by Application
6.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption and Market Share by Application (2013-2018)
6.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Alpha- Antitrypsin Deficiency Treatment Manufacturers Profiles/Analysis
7.1 Adverum Biotechnologies, Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Alnylam Pharmaceuticals, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Applied Genetic Technologies Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Arrowhead Pharmaceuticals, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Carolus Therapeutics, Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Cevec Pharmaceuticals GmbH
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Dicerna Pharmaceuticals, Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Digna Biotech, S.L.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Editas Medicine, Inc.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Grifols, S.A.
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Inhibrx
7.12 Intellia Therapeutics, Inc.
7.13 International Stem Cell Corporation
7.14 Ionis Pharmaceuticals, Inc.
7.15 Kamada Ltd.
7.16 Polyphor Ltd.
7.17 ProMetic Life Sciences Inc.
7.18 rEVO Biologics, Inc.
7.19 Sangamo BioSciences, Inc.
8 Alpha- Antitrypsin Deficiency Treatment Manufacturing Cost Analysis
8.1 Alpha- Antitrypsin Deficiency Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast (2018-2025)
12.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2018-2025)
12.2 Global Alpha- Antitrypsin Deficiency Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Alpha- Antitrypsin Deficiency Treatment Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Alpha- Antitrypsin Deficiency Treatment Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Alpha- Antitrypsin Deficiency Treatment
Figure Global Alpha- Antitrypsin Deficiency Treatment Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Market Share by Types (Product Category) in 2017
Figure Product Picture of CT-2009
Table Major Manufacturers of CT-2009
Figure Product Picture of POL-6014
Table Major Manufacturers of POL-6014
Figure Product Picture of ARO-AAT
Table Major Manufacturers of ARO-AAT
Figure Product Picture of ALNAAT-02
Table Major Manufacturers of ALNAAT-02
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption (K Pcs) by Applications (2013-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Applications in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Alpha- Antitrypsin Deficiency Treatment Major Players Product Production (K Pcs) (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Production Share by Manufacturers (2013-2018)
Figure 2017 Alpha- Antitrypsin Deficiency Treatment Production Share by Manufacturers
Figure 2017 Alpha- Antitrypsin Deficiency Treatment Production Share by Manufacturers
Figure Global Alpha- Antitrypsin Deficiency Treatment Major Players Product Revenue (Million USD) (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Manufacturers
Table 2018 Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Manufacturers
Table Global Market Alpha- Antitrypsin Deficiency Treatment Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Alpha- Antitrypsin Deficiency Treatment Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Alpha- Antitrypsin Deficiency Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Category
Figure Alpha- Antitrypsin Deficiency Treatment Market Share of Top 3 Manufacturers
Figure Alpha- Antitrypsin Deficiency Treatment Market Share of Top 5 Manufacturers
Table Global Alpha- Antitrypsin Deficiency Treatment Capacity (K Pcs) by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity Market Share by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity Market Share by Region (2013-2018)
Figure 2017 Global Alpha- Antitrypsin Deficiency Treatment Capacity Market Share by Region
Table Global Alpha- Antitrypsin Deficiency Treatment Production by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Market Share by Region (2013-2018)
Figure 2017 Global Alpha- Antitrypsin Deficiency Treatment Production Market Share by Region
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Region (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2013-2018)
Table 2017 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption (K Pcs) Market by Region (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Region (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Region (2013-2018)
Figure 2017 Global Alpha- Antitrypsin Deficiency Treatment Consumption (K Pcs) Market Share by Region
Table North America Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) by Type (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Production Share by Type (2013-2018)
Figure Production Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure 2017 Production Market Share of Alpha- Antitrypsin Deficiency Treatment by Type
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure 2017 Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Type
Table Global Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) by Type (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Growth by Type (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption (K Pcs) by Application (2013-2018)
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Application (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Applications (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Application in 2017
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
Table Adverum Biotechnologies, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (Adverum Biotechnologies, Inc.) and Gross Margin (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Alnylam Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Applied Genetic Technologies Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Arrowhead Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Carolus Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Cevec Pharmaceuticals GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Dicerna Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Digna Biotech, S.L. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Editas Medicine, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Grifols, S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Figure Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
Figure Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
Table Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
Table Major Buyers of Alpha- Antitrypsin Deficiency Treatment
Table Distributors/Traders List
Figure Global Alpha- Antitrypsin Deficiency Treatment Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Price (Million USD) and Trend Forecast (2018-2025)
Table Global Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Market Share Forecast by Region (2018-2025)
Table Global Alpha- Antitrypsin Deficiency Treatment Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share Forecast by Region (2018-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Alpha- Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Pcs) Forec
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs